This contract expires in 94 days (Jul 20, 2026).
FIRM FIXED PRICE
BRISTOL-MYERS SQUIBB COMPANY - CAMZYOS, POMALYST, AND REVLIMID
PIID: 36C26026F0154
Signed Date: Jan 16, 2026Effective Date: Jan 20, 2026End Date: Closes in 94 days
Key Details
Description
CAMZYOS, POMALYST, AND REVLIMID
Contractor Information
Contractor: BRISTOL-MYERS SQUIBB COMPANY
UEI: UFGKB2B71N12
CAGE Code: 4K2D9
Location: LAWRENCEVILLE, NJ
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.